Two gorillas, one marketplace — and Waymo just walked out the door. This week Luke and Krzysztof tear apart three King of the Jungle stocks with real money on the line, debate whether active fund management is structurally broken, and wade into the most confusing rights offering either of them has ever seen. Buckle up.

💀 Fundsmith, the legendary UK fund manager just abandoned his own principles — and Luke says it proves you should NEVER give your money to an active manager, no matter how good their track record

🤖 Waymo ditched Uber's platform to go solo. Luke owns $UBER. Is his entire thesis now in jeopardy — or is this actually fine?

🚗 $TSLA at 180x earnings: is it a car company, an AI company, or just a Musk narrative trade? The hosts disagree on when, or whether, to buy

💊 Krzysztof makes the case for $PRCT (Procept BioRobotics) at near all-time lows and explains exactly what he's watching in the August 5th earnings call before he adds a single share

🎯 Down 40% on a position and refusing to add, Krzysztof walks through the discipline behind sitting on your hands when every instinct says buy

🎓 The Fundsmith collapse explained: why "do nothing" is the right strategy for YOU but a career-ending strategy for a fund manager — and why that misalignment matters

⚡ EOS Energy's rights offering has become a genuine disaster — death spiral mechanics, four-cent warrants, and brokers who have no idea what's happening. Krzysztof breaks it all down and tells you what to do RIGHT NOW if you're a holder

Segments:

00:00:00 Cold Open

00:11:00 Fundsmith's Fallure: Why Even the Best Fund Managers Crack

00:20:13 $PRCT Procept BioRobotics — Near All-Time Low, August 5th Catalyst

00:36:13 How to Sit on Your Hands When You're Down 40%

00:41:20 $TSLA Tesla — Car Company, AI Play, or Pure Narrative?

00:54:07 $UBER vs Robotaxi: Does Uber Survive If Waymo Goes Solo?

01:01:00 The Gorilla Problem: Why Krzysztof Isn't Convinced on $UBER

01:13:37 $EOS Energy Rights Offering Disaster — What Holders Must Do Now

01:23:11 Learning in Public: Why We Don't Delete Our Mistakes

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Keywords:

$UBER, $TSLA, $PRCT, $EOS, Procept BioRobotics, Tesla robotaxi, Uber Waymo, Fundsmith Terry Smith, active management, rights offering, aquablation, Optimus robot, full self-driving FSD, robotaxi investing, network effects, position sizing, investing psychology, King of the Jungle portfolio, razor blade business model, med tech investing, EOS Energy warrants, retail investor mistakes, anchoring bias, compounding stocks, growth investing

The AI hacking apocalypse is closer than you think — and two companies are quietly positioning themselves as the last line of defense for every business on earth. This week, Badger makes the bull case for the two cybersecurity gorillas dominating the sector, Monkey digs into a beaten-down beauty-tech turnaround with a suspiciously fixable problem, and together they rain cold water on one of the hottest narratives in investing right now.

🛡️ $CRWD vs $PANW — Badger owns both and is adding more. But are these priced-for-perfection giants still a buy at nosebleed valuations, or is the AI tailwind big enough to justify the premium?

🤖 Project Glasswing: Why Anthropic quietly handed $CRWD and $PANW a massive moat over every other cybersecurity vendor — and what it means for the companies left out in the cold.

🧠 Quantum computing: hype, hope, or the most uninvestable sector on the planet? Badger and Monkey deliver a blunt verdict that Andreas from Patreon definitely didn't want to hear.

🎯 Monkey's contrarian bet on Oddity $ODD — a 49% single-day collapse, a Meta algorithm crisis, and a balance sheet that's almost as big as the market cap. Is this the setup he's been waiting for?

📊 The real numbers behind Palo Alto's "31% revenue growth" — and why that headline figure is smoke and mirrors hiding a very different story.

🎓 Why waiting for quantum computing to prove itself isn't cowardice — it's strategy. The Nvidia lesson every early-stage tech investor needs to hear.

Segments:

00:00:00 Cold Open: AI Hacking & The Cybersecurity Reckoning

00:01:09 Intro

00:04:50 Quantum Computing: Uninvestable Hype or Early Opportunity?

00:15:30 Why You Don't Need to Be Early — The Nvidia Lesson

00:19:32 Oddity: Beauty-Tech Turnaround or Meta Dependency Trap? $ODD

00:28:34 $ODD Balance Sheet Deep-Dive: Trading at Cash Value?

00:39:00 $CRWD CrowdStrike: The AI-Native Security Gorilla

00:49:33 $PANW Palo Alto Networks: Cheaper Giant or Frankenstein Platform?

00:58:16 $CRWD vs $PANW: Which One Do You Actually Buy?

01:05:00 Project Glasswing: Why Anthropic Just Changed the Cybersecurity Game

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

What if the secret edge in investing isn't a spreadsheet — it's a story? This week Luke and Krzysztof sit down with Daniel Joshua Rubin, screenwriter, author of *27 Essential Principles of Story*, and a self-described "narrative investor" who's been quietly compounding by asking one question: is this a hero worth backing? The conversation gets spicy fast, with all three disagreeing on where narrative ends and delusion begins.

🎓 Daniel breaks down why ALL investing is storytelling

🧠 The Reese's Peanut Butter Cup theory of investing: why numbers alone and narrative alone both fail, and what happens when you combine them

💀 Survivorship bias hits hard — for every Netflix, there are 99 narratives that died quietly on the side of the road. How do you tell the difference *before* the crash?

📊 Luke pulls up the $ZM chart live and shows exactly when the narrative AND the numbers broke down simultaneously — and why one without the other got investors wrecked

🎯 The "drunken pilot" test: Daniel's framework for spotting a bad CEO before the numbers catch up — and why the math guys always miss it

🌐 From Blockbuster's villain arc to CrowdStrike's redemption story to Trade Desk's gathering storm — real companies dissected as hero's journeys

🤖 Nebius vs. the field, Reddit's narrative moat, and why Daniel thinks consumer-facing brands are where narrative investing has the sharpest edge

🎴 The pop quiz that stumped everyone: what do you do when a terrible narrative produces a 12X return? (Aehr Test Systems says hello) $AEHR

Sources:

Daniel Joshua Rubin: https://storyprinciples.com/

Segments:

00:00:00 What Is Narrative Investing? The Core Idea

00:10:20 Story Structure Meets Stock Analysis: Hero, Villain, Object of Desire

00:18:44 Survivorship Bias: The Dark Side of Narrative Investing

00:23:28 $ZM Zoom Case Study: When Narrative and Numbers Both Break

00:30:27 What Great CEOs Look Like — Grit, Humility, and Quiet Intensity

00:38:43 The Drunken Pilot Test: Spotting Bad Leadership Before the Numbers Do

00:51:33 $CRWD CrowdStrike, Trade Desk, and Branding as a Signal

00:59:48 Numbers vs. Narrative: Do You Actually Need Both?

01:09:09 Aehr Test Systems and the Limits of Narrative Investing

01:17:52 Final Verdicts: Where Narrative Has an Edge (and Where It Doesn't)

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Two companies making the world genuinely better — one a glowing eyeball printing money in the desert, the other a century-old drug giant that invented the obesity revolution. So why are both kind of terrible investments right now? Luke and Krzysztof go head-to-head on $SPHR (Sphere Entertainment) and $NVO (Novo Nordisk) in this week's King of the Jungle bull-bear debate — and the tension is real.

🎯 Krzysztof bought $SPHR at ~$50. It's now $150. Is it a 3-bagger worth holding — or time to squeeze the last drop from the lemon?

📊 $NVO is trading at 10x earnings while $LLY trades at 40x. Screaming value trap or generational discount? Luke makes the case — then almost talks himself out of it live on air.

🌐 SpaceX IPO day sparks a bigger debate: why a company losing $10B still justifies a $2.2T valuation — and what most investors get wrong about forward-looking markets.

🧠 "You can love a company and hate the stock." The uncomfortable investing truth both hosts keep circling back to — and what it means for YOUR portfolio.

🚀 SpaceX vs Meta: Krzysztof breaks down why comparing current financials is almost meaningless — and the one bias both hosts admit they share about Zuckerberg's empire.

💊 Novo Nordisk's Cagrisema failed its head-to-head vs Lilly. The stock dropped 45% in a year. Luke owns it anyway. Krzysztof has zero desire to touch it. Who's right?

🎯 The Sphere's real constraint isn't content — it's geography. Luke makes the bear case: how many cities on Earth can actually host one of these things profitably?

🤖 When good stories get too well-known, the edge disappears. Krzysztof shares why he's increasingly hunting investments he doesn't even *like* — purely on the investment case.

Segments:

00:00:00 Cold Open: Loving a Company vs Loving the Stock

00:00:49 Intro + SpaceX IPO Day — Options Strategy & What Comes Next

00:04:31 SpaceX vs Meta: Why Comparing Current Financials Misses the Point

00:11:17 $SPHR Bull Case: How the Giant Glowing Eyeball Learned to Print Money

00:15:33 $SPHR Bear Case: How Many Cities Can Actually Host a Sphere?

00:22:39 $SPHR Verdict: Would You Buy at $150? (Krzysztof Answers Honestly)

00:30:23 $NVO Deep Dive: Novo Nordisk — Cheap for a Reason or Generational Value?

00:36:32 $NVO vs $LLY: 10x Earnings vs 40x — Is the Gap Justified?

00:40:28 Why Luke Hasn't Sold $NVO Yet (And Why That Might Be a Mistake)

00:46:51 The Meta-Lesson: When Knowing the Story Kills Your Edge

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Keywords:

$SPHR, $NVO, Novo Nordisk, Sphere Entertainment, $LLY, Eli Lilly, SpaceX IPO, Ozempic, Wegovy, semaglutide, weight loss stocks, value trap, growth investing, forward-looking valuation, position sizing, dividend investing, options strategy, implied volatility, biotech investing, love the company hate the stock, Meta vs SpaceX valuation, Las Vegas Sphere, compounding stocks

Two years ago, Badger called EOS Energy garbage. Monkey wouldn't shut up about it. Today, the stock is up 1,000% and the story is just getting stronger. This week on Wall Street Wildlife, we settle the $EOSE vs $AXON bet, dissect a rights offering that could make or break $EOSE shareholders, and go live on SpaceX IPO day to watch history happen in real time.

🚀 SpaceX opens at $160+ on IPO day — Badger and Monkey called it live, almost to the dollar, and neither can quite believe it

📊 $EOSE is up 1,000% since the bet was made — but was it 3,000% at the peak, did Monkey leave serious money on the table?

💀 The rights offering explained: dilution is coming for $EOSE shareholders — but is it actually a gift in disguise, or a warning sign?

🎯 Badger bought back into $AXON after cutting it — what changed, what still bothers him, and why Motorola just became a threat worth watching

🧠 Why can't two investors who trust each other actually pull the trigger on each other's best ideas? The psychology of the "stock tip problem"

🦫 Monkey's Samantha Rabbit vs. Monkey daily stock-picking experiment: week three update, early surprises, and a new options data module for Patreons

🌴 The show identity question: are WSW just two animals shooting the sh*t, or is there a responsibility to say more when a stock goes up 450%?

Segments:

00:00:00 Introduction & SpaceX IPO Day Live

00:02:05 SpaceX Price Bet: Badger vs. Monkey (Live)

00:05:30 What Is Wall Street Wildlife Actually For?

00:11:35 Samantha Rabbit vs. Monkey: Week 3 Update

00:19:26 How to Start Investing (Badger's On-Ramp Principles)

00:21:00 The EOS Energy vs. Axon Bet: Two-Year Results Revealed

00:27:01 $EOSE Deep Dive: Rights Offering, Cerberus & Frontier Power USA

00:49:31 $AXON Deep Dive: Why Badger Sold, And Why He Bought Back

01:01:38 Motorola vs. Axon: The Counter-Drone War Begins

01:03:25 SpaceX IPO Price Confirmed Live — $2 Trillion Valuation $SPCX

01:05:07 SpaceX: Top 5 Company in 8 Years? Badger vs. Monkey

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Keywords:

$EOSE, $AXON, SpaceX IPO, rights offering, long-duration energy storage, zinc batteries, Cerberus Capital, Frontier Power USA, counter-drone investing, Dedrone, Motorola Solutions, reverse DCF, stock-based compensation, position sizing, dilution explained, investing psychology, stock tip problem, $ASTS, Kelly Criterion, retail investor on-ramp, options strategy, King of the Jungle portfolio, Wall Street Wildlife, WSW, growth investing, contrarian investing, $SPCX

SpaceX is finally going public and it might be the most hyped IPO in a generation. But does that make it a buy, a trade, or a trap? Luke and Krzysztof have completely different plans, and neither one is obvious. This week also covers a tiny autonomous aviation startup that jumped 30% on a massive red day, why Luke dumped $WISE and owns $NU instead, and why the easy money on big IPOs is almost never made by the people watching from home.

🚀 Luke owns SpaceX *already* — but he's locked out, taxed, and has zero control over what happens next. His plan is more complicated than you'd think. $SPCX

🎴 Krzysztof refuses to be a long-term SpaceX holder — and instead wants to swing trade the IPO hype with options. Is he right to ignore the Rocket Lab lesson?

🎯 The musical chairs problem: why retail investors almost always arrive after the easy money is gone — and what to do about it.

🤖 A tiny pre-revenue company called $MRLN (Merlin) jumped 30% on one of the worst market days in months after a US Special Operations milestone. Krzysztof bought it impulsively. Was it genius or madness?

🎓 Is autonomous flying actually *easier* to solve than self-driving cars? Krzysztof makes the contrarian case and braces for pushback from a pilot in the Patreon community.

💰 Luke sold every share of $WISE after the AML scandal deepened and explains exactly why a 2-3 year regulatory headache makes it uninvestable right now, even if the business model is sound.

📊 $NU (Nubank) serves over 135 million customers, more than half of all adults in Brazil. Luke breaks down why it's trading at just 13x forward earnings despite 40% loan book growth, and what the real bear case actually is.

🌴 Krzysztof offers to document his live SpaceX options trades in real time for Patreon Dolphins. Tune in if you want to watch a philosopher-investor try to outsmart the hype machine.

Segments:

00:00:00 The Musical Chairs Problem With IPOs

00:01:06 SpaceX IPO Week — What's Actually Happening

00:05:45 Luke's SpaceX Position: Locked Up, Taxable & Out of Control

00:09:24 Luke's Plan to Build a Real $SPCX Position

00:12:26 Krzysztof's Contrarian Take: Swing Trade the Hype, Don't Own It

00:20:21 $MRLN Merlin Inc — Autonomous Flight for the US Military

00:24:00 Is Autonomous Flying Easier Than Self-Driving Cars?

00:33:39 The Bear Case for Merlin: No Revenue, 200x Sales

00:39:53 Why Luke Sold All His $WISE Stock

00:45:07 $NU Nubank — Banking Half of Brazil at 13x Earnings

00:53:14 The Nubank Bear Case: Loan Book Risk in a Developing Market

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Keywords:

SpaceX IPO, $SPCX, IPO investing, retail investor traps, IPO hype cycle, Merlin Inc, $MRLN, autonomous aviation, autonomous flight, military tech stocks, Wise AML scandal, $WISE, Nubank, $NU, Brazil fintech, neobank investing, options trading IPO, swing trading, pre-revenue stocks

Where the worlds of technology, business, finance, stock markets, and animal spirits collide.

Perfect for those who know there’s an intelligent and principled way to become wealthy but haven’t yet had a good jungle guide, Luke ‘The Badger 🦡’ Hallard and Krzysztof ‘Monkey 🍌’ Piekarski bring you investing insights and principles to help you better understand how to make $$ money in the stock market.

Wall Street Wildlife is a gateway to deep, quality investing research and principles.

Are you ready to become a beast of an investor? 🦁

The AI infrastructure land grab is accelerating — and this week, Krzysztof drops a deep dive into his #1 portfolio holding that rewrites the bull case entirely. Meanwhile, Luke's longtime fintech darling just got hit with a half-billion-euro money laundering investigation on the same week it relisted on NASDAQ. Timing couldn't be worse. Here's what's really at stake:

🤖 $IREN just went from Bitcoin miner to potential hyperscaler — and NVIDIA's $3.4B bet on their Sweetwater site might be the most important data center deal you haven't heard about

🎯 Krzysztof holds $IREN at 21% of his King of the Jungle portfolio — and after this earnings call, he's not trimming. Here's why that conviction is earned, not reckless

📊 The revenue miss that spooked the algos vs. the thesis that actually matters — why Krzysztof calls it a "nothing burger" and what would change his mind

🌐 $IREN vs. CoreWeave vs. Nebius: the neo-cloud battle nobody's framing correctly — and the one financial metric that makes CoreWeave a no-touch for Monkey

💰 $WISE drops 18% on AML bombshell — Luke worked in global anti-money laundering for a major bank, and his read is genuinely alarming. This isn't a dip-buy moment

🎴 SpaceX IPO ticker confusion is already making people rich — the meme crew is running a pump on Virgin Galactic $SPCE and it's equal parts hilarious and predatory

🧠 What would Rafa Nadal's grit look like in a retail investor? The question that reframes every market downturn you'll ever face

Segments:

00:00:56 Welcome + Episode Overview

00:02:25 Rafa Nadal Documentary: The Grit Investors Are Missing

00:09:53 Monkey vs. Samantha the Rabbit: AI Stock Picker Experiment Update

00:14:31 Daily Investment Decisions — Good Habit or Bad Habit?

00:23:02 SpaceX IPO Ticker Trap: The $SPCE Meme Pump Explained

00:30:29 $IREN Deep Dive: From Bitcoin Miner to NVIDIA's Chosen Partner

00:43:00 $IREN vs. CoreWeave vs. Nebius: Why Krzysztof Chose the Land

00:59:31 $IREN Position Sizing: Is 21% of a Portfolio Ever Justified?

01:01:26 $WISE AML Scandal: Luke's Inside Take from His Banking Past

01:13:09 Would Luke Buy or Sell $WISE Today? Live Portfolio Decision

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Keywords:

$IREN, $WISE, $SPCE, SpaceX IPO, NVIDIA data center, AI infrastructure investing, anti-money laundering, AML compliance, neo-cloud stocks, CoreWeave vs IREN, Nebius vs IREN, Sweetwater data center, position sizing, conviction investing, retail investor psychology, investing grit, Rafa Nadal investing mindset, AI stock picker experiment, King of the Jungle portfolio, pre-IPO meme pump, Mirantis acquisition, data center power moat, Wise PLC investigation, fintech regulation risk, Wall Street Wildlife

Four investors. Four wildly different portfolios. One crossover episode that gets uncomfortably honest about conviction, concentration, and whether the rules of investing have actually changed. Wall Street Wildlife's Luke and Krzysztof team up with Bear and Drowsy from Shooting the Bull Pod — and the result is one of the most candid portfolio conversations we've ever recorded.

🤖 One investor is sitting on a 43% Nvidia position — and his defense of it might actually change your mind about concentration risk

🎯 Bear vs. Drowsy vs. Badger vs. Monkey: four real portfolios laid side-by-side, and the differences are stark — who's right?

🌐 Has the Law of Large Numbers been repealed? $NVDA at $5T, Micron hitting $1T, Anthropic at $1T private — is gravity still a thing?

🧠 The trimming problem: why Bear sells too early, why Drowsy almost never sells, and the psychological trick that separates long-term winners from hyperactive traders

🚀 $RKLB and $ASTS under the microscope — are space stocks the real opportunity hiding in plain sight, or another 3D printing moment?

💀 A mea culpa on NeoClouds: Drowsy admits they "got it completely wrong" on Nebius — and what that confession reveals about investing humility $NBIS

🎓 Krzysztof's evolution from quality-compounder to rock-flipper: the philosophical pivot that explains everything about his portfolio today

🌴 Dark horse stocks nobody's talking about: Hinge Health, Oddity, MercadoLibre, Sterling Infrastructure, Palo Alto Networks — the roundtable gets spicy at the end $HNGE $ODD $MELI $STRL $PANW

Sources:

Shooting the Bull podcast: https://open.spotify.com/show/5qH1zzezA4EnHHGibgzJlb

Growth Stock Investing subreddit: https://www.reddit.com/r/GrowthStockInvesting/

Segments:

00:00:00 Four Investors, One Portfolio Showdown — The Crossover Begins

00:05:14 Golden Age of Individual Investing? AI, Community & the New Edge

00:07:54 Is This 2021 Again? What's Different (and Scarier) About This Rally

00:15:19 Defending a 43% $NVDA Position — Drowsy Makes His Case

00:23:10 Portfolio Concentration Debate: Quality Giants vs. Rocks & Rubble

00:35:40 Krzysztof's Confession: Why He Abandoned Blue-Chip Investing

00:43:03 $RKLB Sleep-at-Night Numbers & How Luke Actually Manages Risk

00:59:26 The Practical Trick That Stops You From Trading Too Much

01:05:00 $ASTS Deep Dive: Is Space the Most Overlooked Sector Right Now?

01:16:18 NeoClouds, Nebius & the Stocks They Got Wrong

01:20:01 Final Roundtable: One Stock Each That Deserves More Attention

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

To portfolio track like Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Keywords:

$NVDA, $RKLB, $ASTS, $CRWD, $AXON, Nvidia concentration risk, position sizing, portfolio management, Rocket Lab, AST SpaceMobile, Hinge Health, Oddity ODD, MercadoLibre, Nebius, NeoClouds, law of large numbers, trimming stocks, investing psychology, growth stock investing, Shooting the Bull Pod, AI infrastructure stocks, Micron trillion dollar, SpaceX IPO, technical analysis investing

Three stocks, three debates, one ticking clock. This week on Wall Street Wildlife, Krzysztof drops a live biotech catalyst with a 24-hour window, Luke defends his 20-year 'sugar daddy' holding, and a Latin American e-commerce giant is quietly being stress-tested. Plus: Krzysztof reveals a wild AI experiment he's launching in public — and betting real money against it.

💊 Luke's been holding $ISRG since 2006 without selling a single share — but is robotic surgery's best growth already behind it, or is this still the future of medicine?

📊 Medtronic just got FDA clearance. Competition is finally arriving at Intuitive Surgical's door — and margins are showing it. How worried should long-term holders be?

🧬 Krzysztof makes a live, time-sensitive case for a $2.4B biotech with a catalyst dropping the very next day — and explains why the market may be badly mispricing it. $RLAY

🌐 $MELI is growing revenue at 49% year-over-year — so why has the stock been going south? Luke explains the deliberate margin sacrifice and why he's still buying anyway.

🧠 Luke admits he expects $MELI to keep falling for six months... and bought more anyway. Krzysztof calls this a contradiction. Luke disagrees. Who's right?

🤖 Krzysztof built an AI he named Samantha Rabbit, designed specifically not to lie to him — and he's putting $5/day on himself vs. the machine in a 6-month public stock-picking contest!

Segments:

00:00:00 Cold Open: The Future of Surgery & Live Biotech Catalyst

00:01:13 Intro + King of the Jungle Portfolio Review

00:05:52 Community Portfolio Update: 11 Nominations & Why Pitching Changes Everything

00:11:28 $ISRG Deep Dive: Is Intuitive Surgical Still Worth Owning After 20 Years?

00:20:28 $ISRG Bear Case: Competition, GLP-1s, and Flat Margins

00:30:46 Relay Therapeutics: The Biotech With a 24-Hour Catalyst

00:44:42 Relay Bear Case: One-Trick Pony or Magical Molecule?

00:54:48 $MELI Deep Dive: Is Mercado Libre's Investment Phase a Buying Opportunity?

01:05:37 $MELI Bear Case: Emerging Market Risk & Shrinking Margins

01:12:09 Big Reveal: Krzysztof Builds an AI Stock Picker & Bets Against It

**********

If you want to see our furry faces, this podcast is also available on YouTube at ⁠youtube.com/@WallStreetWildlife?sub_confirmation=1⁠

**********

SUPPORT THE SHOW AND BECOME A PATREON:

wallstreetwildlife.com

**********

Follow us at:

⁠⁠x.com/7LukeHallard

⁠x.com/7FlyingPlatypus

**********

Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.

Get 15% off any premium plan with:

fiscal.ai/wildlife

**********

Monkey’s “Zen, Nietzsche, How to Live” Substack:

firephilosophy.substack.com

**********

To use the same portfolio tracking tool as Luke, check-out:

portseido.com/?fpr=lukehallard

**********

Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation

**********

Fed up with the stock market giving you a hard time?

- Invest like seasoned pros with over 40 years in the game

- Discover the world's leading companies

- Sharpen your best investing practices and ditch the worst

- Learn how to start investing

- Essential investing principles to boost your returns

Keywords:

$ISRG, $MELI, Relay Therapeutics, Intuitive Surgical, Mercado Libre, robotic surgery investing, biotech catalyst, PI3K inhibitor, GLP-1 impact on surgery, Latin America e-commerce, emerging market stocks, AI stock picking, position sizing, biotech binary event, razor and blades business model, gross margin compression, compounding stocks, long-term investing, King of the Jungle portfolio, community portfolio, Wall Street Wildlife, growth investing, contrarian biotech, clinical trial investing